Document:

Exhibit
10.8

 

SERVICES
AGREEMENT

 

THIS
SERVICES AGREEMENT (the “Agreement”) is made and entered into by and between MARIZYME, INC. (hereinafter “MRZM”),
a Nevada corporation, and James Sapirstein (hereinafter “Sapirstein”), with the Effective Date of March 1,
2021.

 

RECITALS

 

WHEREAS,
MRZM desires to engage Sapirstein to carry out services more fully described on the attached Exhibit A, attached hereto and made
a part hereof, (the “Services”); and

 

WHEREAS,
SAPIRSTEIN has skill and experience in providing the Services and desires to assist MRZM as set forth herein;

 

Now
THEREFORE, in consideration of the premises, the mutual obligations specified in this Agreement, and other good and valuable consideration,
the receipt and value of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby agree as follows:

 

	1.	Engagement.
    MRZM hereby retains SAPIRSTEIN, and SAPIRSTEIN hereby accepts such retention, to perform Services for MRZM as set forth
    herein.

 

	2.	Description
    and Performance of Services.

 

a.
Scope and Performance. SAPIRSTEIN shall perform the Services as specifically set forth on Exhibit A in a professional and
timely manner, time being of the essence. SAPIRSTEIN shall promptly begin performance of the Services and, shall complete the
Services within the period specified on Exhibit A (the “Service Period”). The performance of the Services shall be
carried out in cooperation with designated MRZM contact: SAPIRSTEIN shall perform the Services at its principal place of business
unless the parties mutually agree otherwise. SAPIRSTEIN shall keep complete, accurate and authentic accounts, notes, data and
records of the Services performed under this Agreement. SAPIRSTEIN shall promptly and fully disclose to MRZM any and, all information,
data and results obtained from conducting the Services (the “Results”), which disclosure shall include, without limitation,
copies of relevant summaries and reports. At the least, a monthly report of all activities performed shall be made in written
format along with any executive summaries and delivered to the MRZM designated contact within three (3) business days following
the end of each monthly Service Period.

 

b.
Third Party Proprietary Rights. SAPIRSTEIN shall not incorporate into or utilize in the performance of the Services, or any
Results or other product thereof, any proprietary rights or inventions of SAPIRSTEIN or any third party, except as SAPIRSTEIN
is freely permitted to do so, with written approval by MRZM, without compensation to SAPIRSTEIN or any third party.

 

	3.	Compensation.

 

a.
Fee. As full and complete compensation for SAPIRSTEIN’s Services and for the discharge of all SAPIRSTEIN’s obligations
hereunder, MRZM shall pay SAPIRSTEIN a Service Fee according to the schedule and other terms set out in Exhibit A.

 

    	Page 1 of 10

    	 

    

 

	4.	Maintaining
    Confidential Information.

 

a.
Confidential Information. During the term of this Agreement and, in the course of SAPIRSTEIN’s performance hereunder, SAPIRSTEIN
may receive or otherwise be exposed to confidential and proprietary information relating to MRZM’s technology, know-how, data,
inventions, developments, plans, business practices and strategies. Such confidential and proprietary information of MRZM (collectively
referred to as “Information”) may include without limitation: (i) confidential and proprietary information supplied to SAPIRSTEIN
with the legend “Confidential” or equivalent; (ii) MRZM’s marketing and customer support strategies, financial information
(including sales, costs, profits and pricing methods), internal organization, employee information, and customer lists; (iii) MRZM’s
technology, including discoveries, inventions, research and development efforts, data, trade secrets, processes, samples, biological
and/or chemical materials (and procedures and formulations for producing any such samples or biological and/or chemical materials), formulas,
methods, products, know-how and show-how; (iv) all derivatives, improvements, additions, modifications, and enhancements to any of the
above, including any such information or material created or developed by SAPIRSTEIN under this Agreement, including, without limitation,
the performance of the Services; and (v) information of third parties as to which MRZM has an obligation of confidentiality and, (vi)
the form of Confidential Information shall be, but not limited to, any and all written forms, electronic transmissions, digital forms,
audio, video, cloud and other forms of documentation, storage, transmittal and collaboration sharing to include technologies, platforms,
social media and other forms of communication that are not in use at the time of the Effective Date of this Services Agreement, but are
invented or modified that comprise the spirit of this Agreement.

 

SAPIRSTEIN
acknowledges the confidential or proprietary character of the Information and agrees that the Information is the sole, exclusive
and extremely valuable property of MRZM. Accordingly, SAPIRSTEIN agrees not to reproduce any of the Information without the prior
written consent of MRZM, not to use the Information except in the performance of this Agreement, and not to disclose all or any
part of the Information in any form (including, without limitation, patent filings of any nature) to any third party, either during
or for a period of ten (10) years after the termination of this Agreement. SAPIRSTEIN shall cause its directors, officers, employees,
agents, consultants or other Related Parties that are provided with the Information to enter into a Nondisclosure Agreement binding
such persons to the obligations of this Section 4. Upon termination of this Agreement for any reason, including expiration of
Term, SAPIRSTEIN agrees to cease using and to destroy or to return to MRZM, at MRZM’s option all whole and partial copies
and derivatives of the Information, regardless of form, including all biological, chemical and other forms of materials, whether
in SAPIRSTEIN’s possession or under SAPIRSTEIN’s direct or indirect control.

 

The
obligations of confidentiality and non-use assumed herein shall not apply to:

 

	 	(1)	information
    which at the time of disclosure is in the public domain; or

 

	 	(2)	information
    which, after disclosure, becomes part of the public domain by publication or otherwise through no act or omission of SAPIRSTEIN
    or its employees; or

 

    	Page 2 of 10

    	 

    

 

	 	(3)	information
    which SAPIRSTEIN can establish by written records was in its possession at the time of disclosure; or

 

	 	(4)	information
    received from a third party who is not under an obligation of confidentiality to MRZM.

 

b.
Other Employer Information. SAPIRSTEIN agrees that it will not, during the Term of this Agreement, improperly use or disclose
any proprietary information or trade secrets of its employees’ former or concurrent employers or SAPIRSTEIN’s clients,
any former or concurrent consulting clients, if any, to MRZM (including, without limitation, during the performance of the Services)
and that it will not bring onto the premises of MRZM any unpublished documents or any property belonging to its employees’
former or concurrent employers or SAPIRSTEIN’s clients unless consented to in writing by said employers or clients.

 

c.
Third Party Information. SAPIRSTEIN recognizes that MRZM has received and in the future will receive from third parties their
confidential or proprietary information subject to a duty on MRZM’s part to maintain the confidentiality of such information
and, in some cases, to use it only for certain limited purposes. SAPIRSTEIN agrees that it owes MRZM and such third parties, both
during the term of its engagement and thereafter, a duty to hold all such confidential or proprietary information in the strictest
confidence and not to disclose it to any person, firm or corporation (except in a manner that is consistent with MRZM’s
agreement with the third party) or use it for the benefit of anyone other than MRZM or such third party (consistent with MRZM’s
agreement with the third party).

 

d.
Survival. This Section 4 shall survive indefinitely the Termination of this Agreement for any reason·, including expiration
of Term.

 

e.
Affiliates. For purposes of this Section 4, the term “MRZM” shall include Marizyme, Inc. and any other company
which is a subsidiary or is affiliated with MRZM.

 

	5.	Assignment
    of Inventions.

 

a.
Inventions Assigned to MRZM. SAPIRSTEIN agrees that any and all ideas, improvements, inventions and/or works of authorship
relating to SAPIRSTEIN’s performance of Services for MRZM under this Agreement (the “Service Product”) shall
be the sole and exclusive property of MRZM. SAPIRSTEIN hereby assigns for MRZM, at no cost to MRZM, all its right, title and interest
in and to any and all such ideas, improvements, inventions and/or works of authorship. SAPIRSTEIN explicitly acknowledges and
agrees that all works of authorship contained in the Service Product are “Works for Hire” under the copyright laws
of the United States and in any country or territory in which similar laws, regulations or forms of protection are afforded, and
that MRZM shall own the copyright in all such works of authorship. SAPIRSTEIN further agrees that MRZM is and shall be vested
with all rights, title and interests, including patent, copyright, trade secret and trademark rights, in all of SAPIRSTEIN’s
Service Product under this Agreement. This subsection 5(a) shall survive indefinitely the Termination of this Agreement for any
reason, including expiration of term.

 

    	Page 3 of 10

    	 

    

 

b.
Obtaining Letters Patent, Copyright Registrations and Other Protection. SAPIRSTEIN agrees to assist MRZM in every reasonable
way to obtain and enforce United States and foreign proprietary rights relating to any and all inventions, original works of authorship,
developments, improvements or trade secrets of MRZM in any and all countries. To that end, SAPIRSTEIN agrees to execute, verify
and deliver such documents and perform such other acts (including appearing as a witness) as MRZM may reasonably request for use
in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such proprietary rights and the assignment thereof.
In addition, SAPIRSTEIN agrees to execute, verify and deliver assignments of such proprietary rights to MRZM or its designee.
SAPIRSTEIN’s obligation to assist MRZM with respect to proprietary rights in any and all countries shall continue beyond
the Termination of this Agreement, but MRZM shall compensate SAPIRSTEIN at a reasonable rate after such Termination for the time
actually spent by SAPIRSTEIN at MRZM’s request on such assistance. SAPIRSTEIN hereby waives and quitclaims to MRZM any and
all claims of any nature whatsoever which SAPIRSTEIN now or may hereafter have for infringement of any proprietary rights assigned
to MRZM.

 

c.
Power of Attorney. SAPIRSTEIN hereby irrevocably designates and appoints MRZM and its duly authorized officers and agents
as SAPIRSTEIN’s agent and attorney in fact, to act for and on SAPIRSTEIN’s behalf to execute, verify and file, with
the same legal force and effect as if executed by it, any such documents and to do all other lawfully permitted acts to further
the purposes of the preceding paragraph. SAPIRSTEIN hereby agrees to execute and deliver such other documents or instruments from
time to time, including additional general or special powers of attorney to enable MRZM to carry out and accomplish the provisions
of this Section 5 or of other sections of this Agreement.

 

d.
Survival. This Section 5 shall survive indefinitely the Termination of this Agreement for any reason·, including expiration
of Term.

 

	6.	Termination.

 

SAPIRSTEIN
may terminate this Agreement in the event of any nonpayment by MRZM of amounts owed under this Agreement which is not cured within
thirty (30) days of written notice of any such breach.

 

MRZM
may terminate this Agreement for convenience with ten (10) days written notice. In such event, SAPIRSTEIN shall cease work immediately
after receiving notice from MRZM, unless otherwise advised by MRZM. SAPIRSTEIN shall notify MRZM of any noncancellable costs incurred
by SAPIRSTEIN up to the Termination Date and MRZM shall reimburse SAPIRSTEIN for such costs. SAPIRSTEIN shall promptly refund
to MRZM any advance Service Fees pa· id to SAPIRSTEIN in excess of such noncancellable costs.

 

This
Agreement, except as otherwise provided, shall be effective as of the Effective Date and automatically terminate upon completion
of all tasks set forth on Exhibit A, to MRZM’s satisfaction, but in any event no later than the last day of the Service
Period as set forth in Exhibit A.

 

    	Page 4 of 10

    	 

    

 

	7.	Independent
    Contractor Status.

 

It
is understood and agreed that SAPIRSTEIN is an Independent Contractor, is not an agent or employee of MRZM or of any SAPIRSTEIN
affiliated with MRZM. SAPIRSTEIN has no power or authority to act for, represent, or bind MRZM or any SAPIRSTEIN affiliated with
MRZM in any manner. SAPIRSTEIN will not be eligible for any employee benefits, nor will MRZM make deductions from any amounts
payable to SAPIRSTEIN for taxes or insurance. All payroll and employment taxes, insurance, and benefits shall be the sole responsibility
of SAPIRSTEIN. SAPIRSTEIN retains the right (subject, however, to the limitations in Sections 4 and 5) to provide services for
others during the Term of this Agreement and is not required to devote its services exclusively to MRZM (as limited in Section
9 and subject to the faithful and timely performance of SAPIRSTEIN’s obligations under Section 2).

 

	8.	Reports.

 

SAPIRSTEIN
shall provide MRZM with written, electronic, or digital documentation of all Services performed hereunder, promptly after completion
of such work. At the least, SAPIRSTEIN shall provide detailed monthly reports and executive summaries of any, and all activities.

 

	9.	SAPIRSTEIN
    Not to Engage in Conflicting Activities

 

During
the Term of this Agreement, SAPIRSTEIN will not enter into any activity or business arrangement which conflicts with MRZM’s
interests, whether current or reasonably proposed as part of this Service Agreement and SAPIRSTEIN’s obligations under this
Agreement. In view of the sensitive nature of SAPIRSTEIN’s status, MRZM shall have the option of terminating this Agreement
at any time if, in its sole discretion with respect to any activity or business arrangement contemplated by SAPIRSTEIN which may
be relevant to this Section 9.

 

	10.	Compliance
    with Applicable Laws.

 

SAPIRSTEIN
warrants that all work performed under this Agreement, including without limitation, the disposal of materials, complies with
or will comply with all applicable United States and foreign laws and regulations and that all governmental approvals, notifications,
registrations or filings, which need to be obtained or made in connection with the entry into, validity, or performance of this
Agreement has been obtained (“Governmental Approvals”).

 

	11.	Disclaimer
    and Indemnification. 

 

SAPIRSTEIN
WILL INDEMNIFY AND HOLD MRZM HARMLESS FROM ANY AND ALL LOSS, DAMAGE, CLAIMS OR LIABILITY WHICH MIGHT RESULT FROM THE PERFORMANCE
OF SERVICES.

 

	12.	Assignment.

 

This
Agreement is for the direct services of SAPIRSTEIN and may not be assigned by SAPIRSTEIN, nor shall it be assignable by operation
of law, without the prior written consent of MRZM. This Agreement may be assigned at any time by MRZM.

 

    	Page 5 of 10

    	 

    

 

	13.	Inside
    Information - Securities Laws Violations.

 

In
the course of the performance of SAPIRSTEIN’s duties, it is expected that SAPIRSTEIN will receive information which is considered
material inside information within the meaning and intent of the Federal Securities Laws, Rules and Regulations. SAPIRSTEIN will
not disclose this information to others except as authorized by MRZM and will not use this information directly or indirectly
for SAPIRSTEIN or as a basis for advice to any other party concerning any decision to buy, sell, or otherwise deal in MRZM’s
securities or those of any of its affiliated companies.

 

	14.	Legal
    and Equitable Remedies.

 

SAPIRSTEIN
hereby acknowledges and agrees that a remedy at law for damages for a breach of this Agreement will be inadequate, and will be
impracticable and extremely difficult to prove, and further that such a breach would cause MRZM irreparable harm, and that MRZM
shall be entitled to specific performance of SAPIRSTEIN’s obligations under this Agreement, declarative relief and equitable
remedies, including without limitation temporary and permanent injunctive relief, without the necessity of proving actual damages.
SAPIRSTEIN agrees that MRZM shall be entitled to any such equitable relief, including without limitation temporary restraining
orders, preliminary injunctions and permanent injunctions, without the necessity of posting bond or other undertaking in connection
therewith, as well as such further relief as may be granted by a court of competent jurisdiction.

 

	15.	Benefit.

 

The
parties’ rights and obligations under this Agreement will bind and inure to the benefit of their respective successors,
heirs, executors, and administrators and permitted assigns.

 

	16.	Governing
    Law; Severability; Waiver.

 

This
Agreement shall be governed by and construed according to the laws of the State of Florida. MRZM and the SAPIRSTEIN waive each
of their respective rights to a trial by jury. If any provision of this Agreement is found by a court of competent jurisdiction
to be unenforceable, that provision shall be severed, and the remainder of this Agreement shall continue in full force and effect.
All rights and remedies conferred under this Agreement or by law shall be cumulative and may be exercised singularly or concurrently.
Failure by either party to enforce any term hereof shall not be deemed a waiver of future enforcement of that or any other term.

 

    	Page 6 of 10

    	 

    

 

	17.	Complete
    Understanding; Modification.

 

This
Agreement, together with its Exhibits, constitutes the final, exclusive and complete understanding and agreement of MRZM and SAPIRSTEIN
with respect to the subject matter hereof. This Agreement supersedes all prior understandings and agreements relating to such
subject matter, and is entered into without reliance upon any representation, whether oral or written, not stated herein. Any
waiver, modification or amendment of any provision of this Agreement shall be effective only if in writing and signed by the President
or Chief Executive Officer of MRZM and SAPIRSTEIN.

 

	18.	Notices.

 

Any
notices required or permitted hereunder shall be given to the appropriate party at the address specified below or at such other
address as the party shall specify in writing. Such notice shall be deemed given if sent by certified or registered mail with
a confirmation copy sent by facsimile, digital, electronic or other means of notice to the following addresses and digital or
electronic addresses.

 

	 	If
    to MRZM: 	 	If
    to SAPIRSTEIN:
	 	 	 	 
	 	Marizyme,
    Inc. 	 	James
    Sapirstein
	 	555
    Heritage Drive, Suite 200 	 	16812
    Burlington Bristol Lane
	 	Jupiter,
    Florida 33458 	 	Delray
    Beach, FL 33446
	 	Attn:
    Office of the President	 	 
	 	Phone:
    (917) 620-8120	 	Phone:
781-635-4346
	 	Email:
    sseegers@marizyme.com	 	Email
: jsapirstein@marizyme.com

 

	 	With a Copy to :	 	 
	 	 	 	 
	 	Marizyme, Inc.	 	 
	 	555 Heritage Drive	 	 
	 	Jupiter, Florida 33458	 	 
	 	Attn : Legal Dept.	 	 
	 	Email : legal@marizyme.com	 	 

 

	19.	Authority.

 

Each
party hereby represents and warrants that it has the full authority to enter into and perform this Agreement without any third-party
consents or Governmental Approvals, filings, registrations, consents, or permits and that its entry into and performance of this
Agreement will not conflict with any other agreement to which it is a party or by which it is bound.

 

The
remainder of this page left blank intentionally.

 

    	Page 7 of 10

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date set forth above.

 

	MARIZYME,
    INC.	 	JAMES
    SAPIRSTEIN
	 	 	 	 	 
	By:
    	/s/
    Bruce Harmon	 	By:	/s/
    James Sapirstein
	 	Bruce
    Harmon	 	 	 
	 	CFO	 	 	 

 

    	Page 8 of 10

    	 

    

 

EXHIBIT
A

 

	A.	Description
    of Services.

 

SAPIRSTEIN
shall provide and deliver report(s) presenting results of the work under the Project Scope contained within this Exhibit A. according
to the following plan. Upon completion of a Phase as outlined in this Exhibit A, SAPIRSTEIN shall not initiate any next Phase
of Services unless authorized in writing by a duly authorized representative of MRZM and only following completion of all prior
Phases of Services.

 

PROJECT
SCOPE. The scope of this Services Agreement will include:

 

Strategic
intelligence services to support Marizyme in each and any department as requested by MRZM personnel assigned to each stated project
under this Services Agreement.

 

Market
research in any form (raw, interim or final) regarding the business or science interests of the company.

 

As
determined by the MRZM requestor, a final report, summary, presentation or other materials deemed necessary by the MRZM requestor
and delivered to the MRZM requestor under this Agreement.

 

The
company or individual under this Agreement, SAPIRSTEIN, shall be retained on a month-to-month basis unless Terminated under this
Agreement. All outstanding expenses, pre-approved in writing, and fees shall be paid monthly at the end of each month in which
services were performed under this Agreement.

 

	B.	Term
    of Service Period.

 

The
Service Period shall be one (1) year commencing on March 1, 2021 and will automatically renew on the anniversary of the Effective
Date of this Agreement unless either party notifies the other party of termination and provides Notice to the other party.

 

	C.	Service
    Fee.

 

MRZM
shall pay SAPIRSTEIN for Services at the rate of Twenty-Thousand Dollars ($20,000) per full month of Services provided.

 

[REST
OF PAGE LEFT BLANK]

 

    	Page 9 of 10

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.

 

	MARIZYME,
    INC.	JAMES
    SAPIRSTEIN
	 	 	 	 
	By:
    		By:
    	             
	Name:	Bruce
    Harmon	 	 
	Title:	CFO
	 	 

 

    	Page 10 of 10Exhibit 10.9

 

 

December 1, 2020

 

Dr. Steven Brooks

4 Deer Creek Court

Reisterstown, MD 21136

 

Dear Steve:

 

We would like to offer you the position as
Chief Medical Officer for Marizyme, Inc. effective December 1, 2020. The position will pay $300,000 annually, an annual discretionary
bonus of potentially 25% of base salary based upon discretionary objectives to be outlined, and 40,000 stock options. The Company
will also provide a benefit package to include health, dental, vision and insurances coverage.

 

We look forward to you joining the Marizyme
team.

 

Sincerely,

 

	/s/ Bruce Harmon	 
	Bruce Harmon	 
	CFO	 

 

Accepted by:

 

	/s/ Steven Brooks	 
	Dr. Steven Brooks 	 

 

	Pc:	Dr. Neil Campbell, CEO
	 	Kari Jacobson, Controller

 

Marizyme,
Inc.

225
Chimney Corner Lane, Suite 2001, Jupiter, FL 33458

561-935-9955
(O) 561-529-4248 (F)

www.marizyme.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]